
Sabiha Naim Qazi
Examiner (ID: 9181)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1612, 1627, 1629, 1611, 1616, 1628, 1621, 1202 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17014083
[patent_doc_number] => 11083702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism
[patent_app_type] => utility
[patent_app_number] => 16/094828
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8065
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094828
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094828 | Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism | Apr 17, 2017 | Issued |
Array
(
[id] => 11992335
[patent_doc_number] => 20170296490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'USE OF LIGNIN-DERIVED ALDEHYDES AS ANTIFUNGAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/489545
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4279
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489545
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489545 | USE OF LIGNIN-DERIVED ALDEHYDES AS ANTIFUNGAL AGENTS | Apr 16, 2017 | Abandoned |
Array
(
[id] => 11742825
[patent_doc_number] => 20170196897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE EPIDERMAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/468975
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16018
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468975 | COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE EPIDERMAL DISEASES | Mar 23, 2017 | Abandoned |
Array
(
[id] => 11727977
[patent_doc_number] => 20170189420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'OXYSTEROLS AND HEDGEHOG SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 15/463904
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 42897
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463904 | OXYSTEROLS AND HEDGEHOG SIGNALING | Mar 19, 2017 | Abandoned |
Array
(
[id] => 12058497
[patent_doc_number] => 20170334841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'TETRACYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/446831
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65472
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446831 | TETRACYCLINE COMPOUNDS | Feb 28, 2017 | Abandoned |
Array
(
[id] => 11956076
[patent_doc_number] => 20170260227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'C17-ALKANEDIYL AND ALKENEDIYL DERIVATIVES OF OLEANOLIC ACID AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/433100
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28644
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433100 | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | Feb 14, 2017 | Issued |
Array
(
[id] => 14715533
[patent_doc_number] => 20190248830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/068190
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068190 | PROLIPOSOMAL TESTOSTERONE UNDECANOATE FORMULATIONS | Jan 8, 2017 | Abandoned |
Array
(
[id] => 13729483
[patent_doc_number] => 20180369209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHODS OF TREATING PULMONARY DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/065384
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 669
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065384 | METHODS OF TREATING PULMONARY DISEASES AND DISORDERS | Dec 21, 2016 | Abandoned |
Array
(
[id] => 11866071
[patent_doc_number] => 20170233356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/376938
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23556
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15376938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/376938 | Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors | Dec 12, 2016 | Issued |
Array
(
[id] => 11866071
[patent_doc_number] => 20170233356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/376938
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23556
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15376938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/376938 | Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors | Dec 12, 2016 | Issued |
Array
(
[id] => 11528600
[patent_doc_number] => 20170088578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Method for Monofluoromethylation of Organic Substrates to Prepare Biologically Active Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/375452
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2712
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375452
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/375452 | Method for Monofluoromethylation of Organic Substrates to Prepare Biologically Active Organic Compounds | Dec 11, 2016 | Abandoned |
Array
(
[id] => 17727739
[patent_doc_number] => 11384114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Polymorphic forms of an oxysterol and methods of making them
[patent_app_type] => utility
[patent_app_number] => 15/374610
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 106
[patent_no_of_words] => 25379
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15374610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/374610 | Polymorphic forms of an oxysterol and methods of making them | Dec 8, 2016 | Issued |
Array
(
[id] => 14852097
[patent_doc_number] => 10414760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Cytochrome P450 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/364211
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 51283
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364211 | Cytochrome P450 inhibitors and uses thereof | Nov 28, 2016 | Issued |
Array
(
[id] => 11992336
[patent_doc_number] => 20170296491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA AMIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/360165
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11923
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/360165 | PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA AMIDE AND USES THEREOF | Nov 22, 2016 | Abandoned |
Array
(
[id] => 15466083
[patent_doc_number] => 10548895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Ligands that target
[patent_app_type] => utility
[patent_app_number] => 15/357760
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 54
[patent_no_of_words] => 12286
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357760 | Ligands that target | Nov 20, 2016 | Issued |
Array
(
[id] => 11491431
[patent_doc_number] => 20170065615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'Steroid Analogues for Neuroprotection'
[patent_app_type] => utility
[patent_app_number] => 15/355416
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 47974
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355416 | Steroid Analogues for Neuroprotection | Nov 17, 2016 | Abandoned |
Array
(
[id] => 11979213
[patent_doc_number] => 20170283368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/351700
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11914
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351700
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351700 | METHODS FOR SYNTHESIZING SUBSTITUTED TETRACYCLINE COMPOUNDS | Nov 14, 2016 | Abandoned |
Array
(
[id] => 11602494
[patent_doc_number] => 20170119794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/344489
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23705
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/344489 | TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF | Nov 3, 2016 | Abandoned |
Array
(
[id] => 11589603
[patent_doc_number] => 20170114013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'LOW CALCEMIC, HIGHLY ANTIPROLIFERATIVE, ANALOGS OF CALCITRIOL'
[patent_app_type] => utility
[patent_app_number] => 15/339883
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22790
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15339883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/339883 | LOW CALCEMIC, HIGHLY ANTIPROLIFERATIVE, ANALOGS OF CALCITRIOL | Oct 30, 2016 | Abandoned |
Array
(
[id] => 11587719
[patent_doc_number] => 20170112131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'METHODS FOR TREATING CITRUS FRUIT TREES'
[patent_app_type] => utility
[patent_app_number] => 15/335995
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2899
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335995
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/335995 | METHODS FOR TREATING CITRUS FRUIT TREES | Oct 26, 2016 | Abandoned |